For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Transform Pharmaceuticals, Inc.

USPTO Granted Patents = 28

% Expired Patents = 75.0

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 434

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Matthew Lynn Peterson (10 out of 31 patents)

Michael John Cima (9 out of 105 patents)

Orn Almarsson (7 out of 22 patents)

4. Julius F Remenar (7 out of 53 patents)

5. Javier Gonzalez-Zugasti (7 out of 12 patents)

6. Anthony Lemmo (7 out of 7 patents)

7. J Richard Gyory (7 out of 100 patents)

8. Hongming Chen (6 out of 8 patents)

9. Örn Almarsson (5 out of 16 patents)

10. Magali Bourghol Hickey (4 out of 7 patents)

11. Julie Monagle (3 out of 3 patents)

12. Michael MacPhee (3 out of 3 patents)

13. Sherry Morissette (3 out of 3 patents)

14. Michael John Zaworotko (3 out of 17 patents)

15. Douglas Adam Levinson (3 out of 45 patents)

28 patents: Sort by Forward Citations

1. 8436029 - Pharmaceutical forms, and methods of making and using the same (2013-05-07),

2. 7927613 - Pharmaceutical co-crystal compositions (2011-04-19),

3. 7915317 - Aqueous 2,6-diisopropylphenol pharmaceutical compositions (2011-03-29),

4. 7803786 - Pharmaceutical co-crystal compositions and related methods of use (2010-09-28),

5. 7772277 - Formulations comprising fenofibrate and a statin, and related methods of treatment (2010-08-10),

6. 7763455 - Raised surface assay plate (2010-07-27),

7. 7763112 - Methods and systems for co-crystal synthesis (2010-07-27),

8. 7671093 - Mixed co-crystals and pharmaceutical compositions comprising the same (2010-03-02),

9. 7642287 - Statin pharmaceutical compositions and related methods of treatment (2010-01-05),

10. 7550155 - Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses (2009-06-23),

11. 7521254 - Quantitative measurements of concentration and solubility using Raman spectroscopy (2009-04-21),

12. 7449342 - Methods of manipulating small amounts of solids (2008-11-11),

13. 7449307 - Raised surface assay plate (2008-11-11),

14. 7446107 - Crystalline forms of conazoles and methods of making and using the same (2008-11-04),

15. 7408632 - Miscibility determination of a combination of liquids (2008-08-05),

Transform Pharmaceuticals, Inc. is a biotechnology company based in Lexington, MA, specializing in the development of innovative drug delivery systems. The company focuses on enhancing the efficacy and safety of therapeutics through advanced formulation technologies. Transform Pharmaceuticals aims to address unmet medical needs by leveraging its expertise in pharmaceutical sciences and engineering, contributing to the advancement of healthcare solutions. Its research initiatives are geared towards improving patient outcomes across various therapeutic areas.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Transform Pharmaceuticals, Inc.

28 Patents

#32 in Lexington, MA

#714 in Massachusetts

#11,997 in US

#23,244 in the World

Lexington, MA, United States of America

Transform Pharmaceuticals, Inc.

Forward Citations = 434

35 inventors:

Matthew Lynn Peterson (10 out of 31 patents)

Michael John Cima (9 out of 105 patents)

Orn Almarsson (7 out of 22 patents)

4. Julius F Remenar (7 out of 53 patents)

5. Javier Gonzalez-Zugasti (7 out of 12 patents)

Please report any incorrect information to [email protected]

Loading…